JOHN L. ABRUZZO, M.D.
This content is PDF only. Please click on the PDF icon to access.
The treatment of systemic sclerosis has been ineffectual despite past enthusiasm for some drugs, notably corticosteroids, dimethyl sulfoxide, epsilon aminocaproic acid, potassium para-amino benzoic acid, and edetate disodium. Recent reports have brought promise of advances in management. The results of renal transplantation have been better than expected (1-3). D-Pencillamine may be effective in early disease (4-6), and the previously inevitable fatal outcome for the patient with severe renal failure and hypertension seems to be reversible with antihypertensive therapy and chronic renal dialysis (7-9).
Diagnosis of scleroderma is rarely difficult in its advanced form. The clinician readily recognizes typical leathery and
ABRUZZO JL. Some Progress with Systemic Sclerosis. Ann Intern Med. 1979;90:117–118. doi: https://doi.org/10.7326/0003-4819-90-1-117
Download citation file:
Published: Ann Intern Med. 1979;90(1):117-118.
Results provided by:
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use